Owlet (OWLT) Competitors $7.39 +0.09 (+1.23%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$7.39 0.00 (0.00%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OWLT vs. LAB, CTKB, SENS, QTRX, QSI, FEIM, MASS, KEQU, RPID, and SEERShould you be buying Owlet stock or one of its competitors? The main competitors of Owlet include Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quanterix (QTRX), Quantum-Si (QSI), Frequency Electronics (FEIM), 908 Devices (MASS), Kewaunee Scientific (KEQU), Rapid Micro Biosystems (RPID), and Seer (SEER). These companies are all part of the "measuring and control equipment" industry. Owlet vs. Its Competitors Standard BioTools Cytek Biosciences Senseonics Quanterix Quantum-Si Frequency Electronics 908 Devices Kewaunee Scientific Rapid Micro Biosystems Seer Standard BioTools (NASDAQ:LAB) and Owlet (NYSE:OWLT) are both small-cap measuring and control equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk. Does the media favor LAB or OWLT? In the previous week, Standard BioTools had 2 more articles in the media than Owlet. MarketBeat recorded 5 mentions for Standard BioTools and 3 mentions for Owlet. Standard BioTools' average media sentiment score of 1.45 beat Owlet's score of 0.57 indicating that Standard BioTools is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Standard BioTools 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Owlet 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in LAB or OWLT? 53.7% of Standard BioTools shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 23.2% of Standard BioTools shares are owned by insiders. Comparatively, 67.1% of Owlet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has better valuation and earnings, LAB or OWLT? Owlet has lower revenue, but higher earnings than Standard BioTools. Owlet is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStandard BioTools$174.43M2.83-$138.88M-$0.35-3.71Owlet$78.10M1.56-$12.54M-$1.43-5.17 Which has more volatility and risk, LAB or OWLT? Standard BioTools has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, Owlet has a beta of 1.8, meaning that its share price is 80% more volatile than the S&P 500. Do analysts prefer LAB or OWLT? Standard BioTools presently has a consensus target price of $2.50, indicating a potential upside of 92.31%. Owlet has a consensus target price of $10.25, indicating a potential upside of 38.70%. Given Standard BioTools' higher probable upside, research analysts plainly believe Standard BioTools is more favorable than Owlet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Standard BioTools 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00Owlet 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Is LAB or OWLT more profitable? Owlet has a net margin of -15.28% compared to Standard BioTools' net margin of -78.24%. Owlet's return on equity of -0.36% beat Standard BioTools' return on equity.Company Net Margins Return on Equity Return on Assets Standard BioTools-78.24% -22.44% -16.74% Owlet -15.28%-0.36%0.20% SummaryOwlet beats Standard BioTools on 9 of the 16 factors compared between the two stocks. Get Owlet News Delivered to You Automatically Sign up to receive the latest news and ratings for OWLT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OWLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OWLT vs. The Competition Export to ExcelMetricOwletTechnology Services IndustryBusiness SectorNYSE ExchangeMarket Cap$120.63M$2.52B$14.77B$20.68BDividend YieldN/A1.59%2.81%3.67%P/E Ratio-5.1719.1124.0529.07Price / Sales1.5681.4068.4066.27Price / Cash23.0445.3226.9422.84Price / Book-3.975.085.074.43Net Income-$12.54M$33.37M$195.86M$994.22M7 Day Performance-9.99%-4.62%-4.24%-3.35%1 Month Performance-10.86%0.59%-1.10%-2.06%1 Year Performance74.70%48.85%28.98%10.15% Owlet Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OWLTOwlet3.5567 of 5 stars$7.39+1.2%$10.25+38.7%+71.9%$120.63M$78.10M-5.17106News CoverageUpcoming EarningsLABStandard BioTools3.3857 of 5 stars$1.39-2.1%$2.50+79.9%-8.5%$539.35M$169.69M-3.97620News CoveragePositive NewsGap DownCTKBCytek Biosciences2.3493 of 5 stars$3.60-4.0%$5.60+55.6%-43.2%$455.97M$197.05M-40.00500Positive NewsUpcoming EarningsSENSSenseonics1.6275 of 5 stars$0.50-7.2%$1.55+209.4%+21.1%$327.76M$23.68M-3.8590QTRXQuanterix2.2425 of 5 stars$6.08-6.3%$13.50+122.0%-58.3%$303.70M$137.42M-4.68460Positive NewsUpcoming EarningsQSIQuantum-Si2.5306 of 5 stars$1.64-8.7%$3.48+112.5%+47.6%$300.02M$3.44M-2.40150Upcoming EarningsGap DownFEIMFrequency Electronics1.2587 of 5 stars$26.30-5.6%N/A+99.3%$255.90M$69.81M10.65200Short Interest ↑Gap DownHigh Trading VolumeMASS908 Devices2.115 of 5 stars$6.95-5.2%$5.33-23.3%+26.4%$249.23M$63.99M-12.8760Positive NewsUpcoming EarningsAnalyst ForecastKEQUKewaunee Scientific1.2155 of 5 stars$58.59+2.2%N/A+0.1%$172.67M$240.47M15.301,239News CoverageRPIDRapid Micro Biosystems3.7088 of 5 stars$3.74-9.9%$8.00+113.9%+388.2%$163.93M$29.65M-3.63200SEERSeer1.9866 of 5 stars$2.18-0.9%$3.00+37.6%+8.7%$128.33M$15.06M-1.55160Upcoming Earnings Related Companies and Tools Related Companies Standard BioTools Alternatives Cytek Biosciences Alternatives Senseonics Alternatives Quanterix Alternatives Quantum-Si Alternatives Frequency Electronics Alternatives 908 Devices Alternatives Kewaunee Scientific Alternatives Rapid Micro Biosystems Alternatives Seer Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OWLT) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Owlet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Owlet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
